<html xmlns:feed="http://www.w3.org/2005/Atom" xmlns:fr="http://www.feedreader.com/ns/3.0" xmlns:frc="http://www.feedreader.com/ns/3.0/frc">
<head>
<META http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>The Economist: Science and technology</title>
<link rel="stylesheet" href="atom.css">
<style>

body {
 font-family: verdana, tahoma;
 font-size: 0.7em;
 line-height: 1.3em;
 padding: 0;
 margin: 0;
}


a, a:link, a:active, a:visited {
 text-decoration: none;
 color: #0088ff;
}

div.entry {
 padding: 0 20px 20px 25px;
 border-bottom: 1px solid #ddd;
}

div.content img {
}

div.active {
 background-color: #f1f5fa;;
}

.read .title a {
 color: #aaa;
}


.read .content {
 color: #555;
}

div.entry .read .title a {
 color: gray;
}

.header {
 padding-top: 20px;
 margin: 0 0 0.2em 0;
}

.title {
 font-size: 1.6em;
 font-family: arial, verdana, tahoma;
 font-weight: bold;
 letter-spacing: -1px;
 line-height: 1.1em;
}

div.details {
 color: gray;
 margin-bottom: 0.5em;
}
div.clear {
 clear:both;
 height: 1px;
 width: 1px;
 font-size: 1px;
 line-height: 1px;
}
span.modified, span.author, span.category {
}

.status a {
 display:block;
 line-height: 0;
 font-size: 0;
 width: 8px; 
 height: 8px;
 margin-top: -1.5em;
 background-repeat: no-repeat;
}

.read .status a {
}






</style>
<base href="http://www.economist.com/">
</head>
<body>
<div class="entry" id="article5511">
<div class="header"><span class="title"><a href="http://www.economist.com/node/21538657?fsrc=rss|sct">Stem cells and medicine: Repairing broken hearts</a></span><span class="status" style="float:right;"></span></div>
<div class="details"><span class="updated">00:00 11/24/2011, </span><span class="source"><a href="http://www.economist.com">The Economist: Science and technology</a></span></div>
<div class="content"><p>  <div class="content-image-full">
    <img src="http://media.economist.com/sites/default/files/imagecache/full-width/images/print-edition/20111119_STP001_0.jpg" alt="" title=""  class="imagecache imagecache-full-width" width="595" height="335" />
    
    
  </div>IT HAS been a mixed week for proponents of regenerative medicine. This is the idea that worn-out organs might be repaired—or even replaced—using stem cells. A stem cell is one that, when it divides, spins off some offspring that remain as stem cells while others turn into functional tissue. Stem cells found in embryos can spin off a wide range of tissue types. Those found in adults are more limited: turning into blood cells, say, or muscle cells.The bad news for those who have hopes of the field is that Geron, an American firm that was a pioneer of the therapeutic use of stem cells, is pulling out of the business. It is ending (or selling, if it can find a buyer) a project that was testing embryonic stem cells as a treatment for people paralysed by injuries to their spinal cords. The reason, it said, is financial. At a time when it is hard to raise new capital, the firm has decided to concentrate on anticancer therapies that, it hopes, are nearer to being commercial propositions than the stem-cell study is.The good news for the field of stem-cell therapy comes from a paper published in this week’s...</p></div>
<div class="clear"></div>
</div>
</body>
</html>
